Formulation and evaluation of poly(lactic-co-glycolic acid) microspheres loaded with an altered collagen type II peptide for the treatment of rheumatoid arthritis

References

• Bäcklund J, Carlsen S, Höger T, Holm B, Fugger L, Kihlberg J, Burkhardt H, Holmdahl R. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanised transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA, 2002;99(15):9960–5
   PubMed Web of Science ®Google Scholar
• Cheng YJ, Zhou Q, Li ZG. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation. Scand J Immunol, 2005;61(3):260–5
   PubMed Web of Science ®Google Scholar
• Chu DF, Fu XQ, Liu WH, Liu K, Li YX. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm, 2006;325(1–2):116–23
   PubMed Web of Science ®Google Scholar
• Deighton CM, Kelly PJ, Walker DJ. Linkage of rheumatoid arthritis with HLA. Ann Rheum Dis, 1993;52(9):638–42
   PubMed Web of Science ®Google Scholar
• Emery P, Dorner T. Optimising treatment in rheumatoid arthritis: A review of potential biological markers of response. Ann Rheum Dis, 2011;70(12):2063–70
   PubMed Web of Science ®Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – A review. Int J Pharm, 2011;415(1–2):34–52
   PubMed Web of Science ®Google Scholar
• He J, Feng M, Zhou X, Ma S, Jiang Y, Wang Y, Zhang H. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm, 2011;416(1):69–76
   PubMed Web of Science ®Google Scholar
• He JT, Su HB, Li GP, Tao XM, Mo W, Song HY. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres. Int J Pharm, 2006;309(1–2):101–8
   PubMed Web of Science ®Google Scholar
• Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Contr Release, 2001;73(2–3):121–36
   PubMed Web of Science ®Google Scholar
• Jiang WL, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev, 2005;57(2005):391–410
   PubMed Web of Science ®Google Scholar
• Katsara M, Minigo G, Plebanski M, Apostolopoulos V. The good, the bad and the ugly: How altered peptide ligands modulate immunity. Expert Opin Biol Ther, 2008;8(12):1873–84
   PubMed Web of Science ®Google Scholar
• Keyser FD. Choice of biologic therapy for patients with rheumatoid arthritis: The infection perspective. Curr Rheumatol Rev, 2011;7(1):77–87
   PubMedGoogle Scholar
• Kim KS, Choi YH, Kim KH, Lee YC, Kim CH, Moon SH, Kang SG, Park YG. Protective and anti-arthritic effects of deer antler aqua-acupuncture (DAA), inhibiting dihydroorotate dehydrogenase, on phosphate ions mediated chondrocyte apoptosis and rat collagen-induced arthritis. Int Immunopharm, 2004;4(7):963–73
   PubMed Web of Science ®Google Scholar
• Kimata M, Cullins DL, Brown ML, Brand DD, Rosloniec EF, Myers LK, Stuart JM, Kang AH. Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis. Arthritis Res Ther, 2012;14(3):R107
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Torres HR, Schafer U, Lehr CM. Biodegradable microparticles as a two-drug controlled release formulation: A potential treatment of inflammatory bowel disease. J Control Release, 2000;69(3):445–54
   PubMed Web of Science ®Google Scholar
• Li R, Li X, Li ZG. Altered collagen II peptides inhibited T cell activation in rheumatoid arthritis. Clin Immunol, 2006;118(2–3):317–23
   PubMed Web of Science ®Google Scholar
• Li R, Li X, Li Z. Altered collagen II 263–272 peptide immunization induces inhibition of collagen-induced arthritis through a shift toward Th2-type response. Tissue Antigens, 2009;73(4):341–7
   PubMed Web of Science ®Google Scholar
• Luckey D, Behrens M, Smart M, Luthra H, David CS, Taneja V. DRB1*0402 may influence arthritis by promoting naive CD4+ T-cell differentiation into regulatory T cells. Eur J Immunol, 2014;44(11):3429–38
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Contr Release, 2008;125(3):193–209
   PubMed Web of Science ®Google Scholar
• Myers LK, Sakurai Y, Rosloniec EF, Stuart JM, Kang AH. An analog peptide that suppresses collagen-induced arthritis. Am J Med Sci, 2004;327(4):212–16
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60(4):110–11
   PubMedGoogle Scholar
• Qian Z, Latham KA, Whittington KB, Miller DC, Brand DD, Rosloniec EF. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis. J Immunol, 2010;185(1):110–18
   PubMed Web of Science ®Google Scholar
• Sandor M, Harris J, Mathiowitz E. A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivo. Biomaterials, 2002;23(22):4413–23
   PubMed Web of Science ®Google Scholar
• Senolt L, Vencovský J, Pavelka K, Ospelt C, Gay S. Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev, 2009;9(2):102–7
   PubMed Web of Science ®Google Scholar
• Shah SS, Cha Y, Pitt CG. Poly(glycolic acid-co-dl-lactic acid): Diffusion or degradation controlled drug delivery. J Contr Release, 1992;18(3):261–70
   Web of Science ®Google Scholar
• Sun Y, Wang J, Zhang X, Zhang Z, Zheng Y, Chen D, Zhang Q. Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: In vitro and in vivo studies. J Contr Release, 2008;129(3):192–9
   PubMed Web of Science ®Google Scholar
• Thomas R. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. Arthritis Res Ther, 2013;15(1):204. doi: 10.1186/ar4130
   PubMed Web of Science ®Google Scholar
• Waksman Y, Hod I, Friedman A. Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII). Clin Exp Immunol, 1996;103(3):376–83
   PubMed Web of Science ®Google Scholar
• Xu Q, Crossley A, Czernuszka J. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres. J Pharm Sci, 2009;98(7):2377–89
   PubMed Web of Science ®Google Scholar
• Yao ZQ, Li R, Li ZG. A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis. Ann Rheum Dis, 2007;66(3):423–4
   PubMed Web of Science ®Google Scholar
• Yao ZQ, Zhao JX, Li R, Li ZG. Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: Experiment with rats. Zhonghua Yi Xue Za Zhi, 2006;86(43):3055–8
   PubMedGoogle Scholar
• Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Contr Release, 2010;146(2):241–60
   PubMed Web of Science ®Google Scholar
• Yuan F, Quan LD, Cui L, Goldring SR, Wang D. Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev, 2012;64(12):1205–19
   PubMed Web of Science ®Google Scholar
• Zhou Q, Cheng YJ, Lu HS, Zhou WH, Li ZG. Inhibition of T-cell activation with HLADR1/DR4 restricted non-T-cell stimulation peptides. Hum Immunol, 2003;64(9):857–65
   PubMed Web of Science ®Google Scholar
• Zhou XL, He JT, Zhou ZT, Ma SF, Jiang Y, Wang Y. Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique. Yao Xue Xue Bao, 2010;45(8):1057–63
   PubMedGoogle Scholar